Wednesday, May 30, 2012

Urinary Proteomics to Support Diagnosis of Stroke

Rather than arguing with ER doctors about your belief you've had a stroke, just hand them a container of your pee. For guys they probably couldn't even stand up long enough, with the additional problem of only one hand to hold the pee cup and your penis. They could rule out drug interactions also. Something similar would need to be done for bleeds. How long after onset of stroke were samples taken? How much faster and accurate than a MRI?
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0035879
Accurate diagnosis in suspected ischaemic stroke can be difficult. We explored the urinary proteome in patients with stroke (n = 69), compared to controls (n = 33), and developed a biomarker model for the diagnosis of stroke. We performed capillary electrophoresis online coupled to micro-time-of-flight mass spectrometry. Potentially disease-specific peptides were identified and a classifier based on these was generated using support vector machine-based software. Candidate biomarkers were sequenced by liquid chromatography-tandem mass spectrometry. We developed two biomarker-based classifiers, employing 14 biomarkers (nominal p-value <0.004) or 35 biomarkers (nominal p-value <0.01). When tested on a blinded test set of 47 independent samples, the classification factor was significantly different between groups; for the 35 biomarker model, median value of the classifier was 0.49 (−0.30 to 1.25) in cases compared to −1.04 (IQR −1.86 to −0.09) in controls, p<0.001. The 35 biomarker classifier gave sensitivity of 56%, specificity was 93% and the AUC on ROC analysis was 0.86. This study supports the potential for urinary proteomic biomarker models to assist with the diagnosis of acute stroke in those with mild symptoms. We now plan to refine further and explore the clinical utility of such a test in large prospective clinical trials.

No comments:

Post a Comment